Magic roundabout, a tumor endothelial marker: expression and signaling

Pankaj Seth1, Yanfeng Lin, Jun-ichi Hanai

  • 1Renal Division and Center for Study of the Tumor Microenvironment, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

Insights

Magic roundabout (MRB) is overexpressed in tumor endothelial cells and inhibits their migration. This finding suggests MRB plays a role in regulating endothelial cell migration during tumor angiogenesis.

Area of Science:

  • Molecular biology
  • Cell biology
  • Oncology

Background:

  • Molecular signals guiding blood vessels are not fully understood but resemble neuronal guidance cues.
  • These cues are vital for normal blood vessel development and crucial in tumor angiogenesis.

Purpose of the Study:

  • To investigate the role of the Robo family member, magic roundabout (MRB), in tumor angiogenesis.
  • To characterize MRB's function in endothelial cell migration and identify its signaling pathway.

Main Methods:

  • Examined MRB expression in tumor versus normal endothelial cells.
  • Assessed MRB's effect on endothelial cell migration, with and without Slit2 stimulation.
  • Investigated the involvement of the Ras-Raf-Mek-Erk pathway in MRB-mediated inhibition.

Main Results:

  • MRB is differentially overexpressed in tumor endothelial cells across various solid tumors.
  • MRB activation, ligand-independent or via Slit2, inhibits VEGF and FGF-induced endothelial cell migration.
  • MRB-induced inhibition of migration is partially mediated by the Ras-Raf-Mek-Erk pathway.

Conclusions:

  • MRB is a tumor endothelial-specific molecule.
  • MRB expression and activation can inhibit endothelial cell migration.
  • MRB is hypothesized to regulate endothelial cell migration in tumor angiogenesis.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...